Gene sequencing company Bionano Genomics (NASDAQ:BNGO) traded ~8% lower in the premarket on Thursday after announcing a 1-for-60 reverse stock split that will take effect on Friday at 5 p.m. In a press release on Wednesday after the market close,

Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a multi-asset, clinical stage, disease-agnostic life science company delivering an efficient model for compound development, announces that its board of directors has approved a 1-for-100 reverse stock split of the Company’s common stock.

Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR), whose stock has declined over 98% in the past year according to InvestingPro data, has announced a one-for-four reverse stock split of its common stock,